{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T09:45:31Z","timestamp":1775555131156,"version":"3.50.1"},"reference-count":31,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81802245"],"award-info":[{"award-number":["81802245"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007128","name":"Shaanxi Province Natural Science Foundation","doi-asserted-by":"publisher","award":["2022JM-562"],"award-info":[{"award-number":["2022JM-562"]}],"id":[{"id":"10.13039\/501100007128","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","pathologyjournal.rcpa.edu.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pathology"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.pathol.2024.06.012","type":"journal-article","created":{"date-parts":[[2024,9,17]],"date-time":"2024-09-17T18:25:15Z","timestamp":1726597515000},"page":"34-39","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["CDK4 gene copy number increase and concurrent genetic changes in acral melanoma of a Chinese cohort"],"prefix":"10.1016","volume":"57","author":[{"given":"Leyuan","family":"Yang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4000-1273","authenticated-orcid":false,"given":"Yan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9349-5983","authenticated-orcid":false,"given":"Ruiping","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan","family":"Du","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lingchao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaolong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianfang","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fang","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4810-6096","authenticated-orcid":false,"given":"Jing","family":"Su","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.pathol.2024.06.012_bib1","doi-asserted-by":"crossref","first-page":"446e","DOI":"10.1097\/PRS.0b013e31829ad411","article-title":"Managing malignant melanoma","volume":"132","author":"Dzwierzynski","year":"2013","journal-title":"Plast Reconstr Surg"},{"issue":"5","key":"10.1016\/j.pathol.2024.06.012_bib2","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1002\/path.5213","article-title":"Melanoma subtypes: genomic profiles, prognostic molecular markers and therapeutic possibilities","volume":"247","author":"Rabbie","year":"2019","journal-title":"J\u00a0Pathol"},{"issue":"4","key":"10.1016\/j.pathol.2024.06.012_bib3","doi-asserted-by":"crossref","first-page":"500","DOI":"10.5858\/arpa.2019-0561-RA","article-title":"The 2018 World Health Organization classification of cutaneous, mucosal, and uveal melanoma: detailed analysis of 9 distinct subtypes defined by their evolutionary pathway","volume":"144","author":"Elder","year":"2020","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.pathol.2024.06.012_bib4","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1186\/1471-2407-11-85","article-title":"Clinical presentation, histology, and prognoses of malignant melanoma in ethnic Chinese: a study of 522 consecutive cases","volume":"11","author":"Chi","year":"2011","journal-title":"BMC Cancer"},{"key":"10.1016\/j.pathol.2024.06.012_bib5","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.semcancer.2019.10.017","article-title":"Translational pathology, genomics and the development of systemic therapies for acral melanoma","volume":"61","author":"Chen","year":"2020","journal-title":"Semin Cancer Biol"},{"issue":"2","key":"10.1016\/j.pathol.2024.06.012_bib6","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1111\/bjd.15600","article-title":"Prognostic factors and survival in acral lentiginous melanoma","volume":"177","author":"Asgari","year":"2017","journal-title":"Br J Dermatol"},{"issue":"1","key":"10.1016\/j.pathol.2024.06.012_bib7","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1186\/s13073-022-01068-0","article-title":"Integrated genomic analyses of acral and mucosal melanomas nominate novel driver genes","volume":"14","author":"Wang","year":"2022","journal-title":"Genome Med"},{"issue":"7653","key":"10.1016\/j.pathol.2024.06.012_bib8","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/nature22071","article-title":"Whole-genome landscapes of major melanoma subtypes","volume":"545","author":"Hayward","year":"2017","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.pathol.2024.06.012_bib9","doi-asserted-by":"crossref","first-page":"5259","DOI":"10.1038\/s41467-020-18988-3","article-title":"Whole-genome sequencing of acral melanoma reveals genomic complexity and diversity","volume":"11","author":"Newell","year":"2020","journal-title":"Nat Commun"},{"key":"10.1016\/j.pathol.2024.06.012_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112531","article-title":"Getting under the skin: the role of CDK4\/6 in melanomas","volume":"204","author":"Guo","year":"2020","journal-title":"Eur J Med Chem"},{"issue":"6","key":"10.1016\/j.pathol.2024.06.012_bib11","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.3390\/cells10061334","article-title":"CDK4\/6 inhibitors in melanoma: a comprehensive review","volume":"10","author":"Garutti","year":"2021","journal-title":"Cells"},{"issue":"7","key":"10.1016\/j.pathol.2024.06.012_bib12","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/j.pathol.2017.08.006","article-title":"Fluorescence in situ hybridisation as an ancillary tool in the diagnosis of acral melanoma: a review of 44 cases","volume":"49","author":"Su","year":"2017","journal-title":"Pathology"},{"issue":"14","key":"10.1016\/j.pathol.2024.06.012_bib13","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1093\/bioinformatics\/btp324","article-title":"Fast and accurate short read alignment with Burrows-Wheeler transform","volume":"25","author":"Li","year":"2009","journal-title":"Bioinformatics"},{"issue":"16","key":"10.1016\/j.pathol.2024.06.012_bib14","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gkq603","article-title":"ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data","volume":"38","author":"Wang","year":"2010","journal-title":"Nucleic Acids Res"},{"issue":"11","key":"10.1016\/j.pathol.2024.06.012_bib15","doi-asserted-by":"crossref","first-page":"3618","DOI":"10.1245\/s10434-013-3089-0","article-title":"Prognosis of acral melanoma: a series of 281 patients","volume":"20","author":"Bello","year":"2013","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"10.1016\/j.pathol.2024.06.012_bib16","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1186\/s12967-022-03856-z","article-title":"Prognostic value of genetic aberrations and tumor immune microenvironment in primary acral melanoma","volume":"21","author":"Huang","year":"2023","journal-title":"J\u00a0Transl Med"},{"issue":"10","key":"10.1016\/j.pathol.2024.06.012_bib17","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1093\/jnci\/djz005","article-title":"Targeted genomic profiling of acral melanoma","volume":"111","author":"Yeh","year":"2019","journal-title":"J\u00a0Natl Cancer Inst"},{"issue":"5","key":"10.1016\/j.pathol.2024.06.012_bib18","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1016\/j.drudis.2020.12.014","article-title":"Recent advances in HER2-targeted delivery for cancer therapy","volume":"26","author":"Dhritlahre","year":"2021","journal-title":"Drug Discov Today"},{"issue":"6","key":"10.1016\/j.pathol.2024.06.012_bib19","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1158\/2159-8290.CD-16-1431","article-title":"An acquired HER2T798I gatekeeper mutation induces resistance to neratinib in a patient with HER2 mutant-driven breast cancer","volume":"7","author":"Hanker","year":"2017","journal-title":"Cancer Discov"},{"issue":"17","key":"10.1016\/j.pathol.2024.06.012_bib20","doi-asserted-by":"crossref","first-page":"2839","DOI":"10.1158\/0008-5472.CAN-22-3558","article-title":"Breast cancer mutations HER2V777L and PIK3CAH1047R activate the p21-CDK4\/6-cyclin D1 Axis to drive tumorigenesis and drug resistance","volume":"83","author":"Cheng","year":"2023","journal-title":"Cancer Res"},{"key":"10.1016\/j.pathol.2024.06.012_bib21","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.pharmthera.2019.03.010","article-title":"Prevalence and role of HER2 mutations in cancer","volume":"199","author":"Cocco","year":"2019","journal-title":"Pharmacol Ther"},{"issue":"2","key":"10.1016\/j.pathol.2024.06.012_bib22","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1093\/emboj\/17.2.384","article-title":"Bim: a novel member of the Bcl-2 family that promotes apoptosis","volume":"17","author":"O'Connor","year":"1998","journal-title":"EMBO J"},{"issue":"15","key":"10.1016\/j.pathol.2024.06.012_bib23","doi-asserted-by":"crossref","first-page":"2299","DOI":"10.1002\/cncr.28725","article-title":"The Bim deletion polymorphism clinical profile and its relation with tyrosine kinase inhibitor resistance in Chinese patients with non-small cell lung cancer","volume":"120","author":"Zhao","year":"2014","journal-title":"Cancer"},{"issue":"2","key":"10.1016\/j.pathol.2024.06.012_bib24","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.canlet.2008.05.029","article-title":"Anoikis resistance and tumor metastasis","volume":"272","author":"Simpson","year":"2008","journal-title":"Cancer Lett"},{"issue":"12","key":"10.1016\/j.pathol.2024.06.012_bib25","doi-asserted-by":"crossref","first-page":"2274","DOI":"10.1093\/annonc\/mdy456","article-title":"CDK4\/6 inhibitors as neoadjuvant treatment in breast cancer-what can we learn?","volume":"29","author":"Brand\u00e3o","year":"2018","journal-title":"Ann Oncol"},{"issue":"10","key":"10.1016\/j.pathol.2024.06.012_bib26","doi-asserted-by":"crossref","first-page":"2990","DOI":"10.1158\/0008-5472.CAN-15-2931","article-title":"Induction of therapeutic senescence in vemurafenib-resistant melanoma by extended inhibition of CDK4\/6","volume":"76","author":"Yoshida","year":"2016","journal-title":"Cancer Res"},{"issue":"9","key":"10.1016\/j.pathol.2024.06.012_bib27","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1158\/2326-6066.CIR-19-0743","article-title":"Activation of CD8+ T cells contributes to antitumor effects of CDK4\/6 inhibitors plus MEK inhibitors","volume":"8","author":"Teh","year":"2020","journal-title":"Cancer Immunol\u00a0Res"},{"issue":"10","key":"10.1016\/j.pathol.2024.06.012_bib28","doi-asserted-by":"crossref","first-page":"2139","DOI":"10.1002\/ijc.31220","article-title":"Palbociclib synergizes with BRAF and MEK inhibitors in treatment na\u00efve melanoma but not after the development of BRAF inhibitor resistance","volume":"142","author":"Martin","year":"2018","journal-title":"Int J Cancer"},{"issue":"7686","key":"10.1016\/j.pathol.2024.06.012_bib29","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/nature25015","article-title":"Cyclin D-CDK4 kinase destabilizes PD-L1 via cullin 3-SPOP to control cancer immune surveillance","volume":"553","author":"Zhang","year":"2018","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.pathol.2024.06.012_bib30","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1016\/j.cell.2018.09.006","article-title":"A\u00a0cancer cell program promotes T cell exclusion and resistance to checkpoint blockade","volume":"175","author":"Jerby-Arnon","year":"2018","journal-title":"Cell"},{"issue":"21","key":"10.1016\/j.pathol.2024.06.012_bib31","doi-asserted-by":"crossref","first-page":"6511","DOI":"10.1158\/1078-0432.CCR-19-0475","article-title":"Genetic aberrations in the CDK4 pathway are associated with innate resistance to PD-1 blockade in Chinese patients with non-cutaneous melanoma","volume":"25","author":"Yu","year":"2019","journal-title":"Clin Cancer Res"}],"container-title":["Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031302524002290?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031302524002290?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,7]],"date-time":"2025-01-07T21:50:30Z","timestamp":1736286630000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0031302524002290"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["S0031302524002290"],"URL":"https:\/\/doi.org\/10.1016\/j.pathol.2024.06.012","relation":{},"ISSN":["0031-3025"],"issn-type":[{"value":"0031-3025","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"CDK4 gene copy number increase and concurrent genetic changes in acral melanoma of a Chinese cohort","name":"articletitle","label":"Article Title"},{"value":"Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pathol.2024.06.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Royal College of Pathologists of Australasia. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}